Chemours Files 8-K: Other Events Notification
Ticker: CC · Form: 8-K · Filed: Sep 3, 2025 · CIK: 1627223
| Field | Detail |
|---|---|
| Company | Chemours Co (CC) |
| Form Type | 8-K |
| Filed Date | Sep 3, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing
Related Tickers: CC
TL;DR
Chemours filed an 8-K for 'Other Events' - no big numbers, just an update.
AI Summary
On September 2, 2025, The Chemours Company filed an 8-K report detailing "Other Events." The filing does not contain specific financial figures or new material agreements but serves as a notification of events relevant to the company's operations and reporting obligations.
Why It Matters
This filing indicates that Chemours has reported events requiring public disclosure, which could include operational updates, regulatory matters, or other significant corporate actions.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for 'Other Events' and does not disclose any immediate financial risks or significant negative developments.
Key Players & Entities
- The Chemours Company (company) — Registrant
- Delaware (location) — State of Incorporation
- 1007 Market Street Wilmington, Delaware 19801 (address) — Principal executive offices
FAQ
What specific 'Other Events' are being reported by The Chemours Company in this 8-K filing?
The provided excerpt of the 8-K filing does not specify the details of the 'Other Events'; it only indicates that this section is being reported.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is September 2, 2025.
What is The Chemours Company's principal executive office address?
The Chemours Company's principal executive office is located at 1007 Market Street, Wilmington, Delaware 19801.
Under which section of the Securities Exchange Act of 1934 is this Form 8-K filed?
This Form 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is the Commission File Number for The Chemours Company's 8-K filing?
The Commission File Number for this filing is 001-36794.
Filing Stats: 404 words · 2 min read · ~1 pages · Grade level 12.6 · Accepted 2025-09-03 06:50:34
Key Financial Figures
- $0.01 — nge on Which Registered Common Stock ($0.01 par value) CC New York Stock Exchan
Filing Documents
- cc-20250902.htm (8-K) — 48KB
- img173612313_0.jpg (GRAPHIC) — 35KB
- 0000950170-25-112670.txt ( ) — 242KB
- cc-20250902.xsd (EX-101.SCH) — 29KB
- cc-20250902_htm.xml (XML) — 4KB
01 Other Events
Item 8.01 Other Events. The Chemours Company (the "Company") announced that its Board of Directors has appointed Independent Director Mary Cranston as Chair of the Board and Alister Cowan to the role of Lead Independent Director, effective September 2, 2025. These appointments follow the departure of Dawn Farrell, who has accepted a position with the Canadian government as the Chief Executive Officer of the newly created Major Projects Office under the Building Canada Act.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. THE CHEMOURS COMPANY By: /s/ Shane Hostetter Shane Hostetter Senior Vice President, Chief Financial Officer Date: September 3, 2025